Aurora Cannabis Inc. (TSE:ACB – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$3.74 and last traded at C$3.76, with a volume of 313521 shares. The stock had previously closed at C$3.86.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the stock. TD cut their price target on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. Canaccord Genuity Group dropped their price objective on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of C$7.17.
Get Our Latest Stock Analysis on ACB
Aurora Cannabis Stock Performance
Aurora Cannabis (TSE:ACB – Get Free Report) last released its earnings results on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. The firm had revenue of C$38.01 million during the quarter. On average, research analysts anticipate that Aurora Cannabis Inc. will post -0.22 EPS for the current year.
About Aurora Cannabis
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
See Also
- Five stocks we like better than Aurora Cannabis
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
